195 related articles for article (PubMed ID: 25510693)
1. Frequent and increased expression of human METCAM/MUC18 in cancer tissues and metastatic lesions is associated with the clinical progression of human ovarian carcinoma.
Wu GJ; Dickerson EB
Taiwan J Obstet Gynecol; 2014 Dec; 53(4):509-17. PubMed ID: 25510693
[TBL] [Abstract][Full Text] [Related]
2. Significance of expression of human METCAM/MUC18 in nasopharyngeal carcinomas and metastatic lesions.
Lin JC; Chiang CF; Wang SW; Wang WY; Kwan PC; Wu GJ
Asian Pac J Cancer Prev; 2014; 15(1):245-52. PubMed ID: 24528033
[TBL] [Abstract][Full Text] [Related]
3. METCAM/MUC18 Plays a Tumor Suppressor Role in the Development of Nasopharyngeal Carcinoma Type I.
Liu YC; Chen YJ; Wu GJ
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362174
[TBL] [Abstract][Full Text] [Related]
4. METCAM/MUC18 is a novel tumor and metastasis suppressor for the human ovarian cancer SKOV3 cells.
Wu GJ; Zeng GF
BMC Cancer; 2016 Feb; 16():136. PubMed ID: 26906545
[TBL] [Abstract][Full Text] [Related]
5. METCAM/MUC18 Decreases the Malignant Propensity of Human Ovarian Carcinoma Cells.
Wu GJ
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274262
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.
Wu GJ; Wu MW; Wang SW; Liu Z; Qu P; Peng Q; Yang H; Varma VA; Sun QC; Petros JA; Lim SD; Amin MB
Gene; 2001 Nov; 279(1):17-31. PubMed ID: 11722842
[TBL] [Abstract][Full Text] [Related]
7. Nuclear survivin is associated with malignant potential in epithelial ovarian carcinoma.
Qian X; Xi X; Li L
Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):126-32. PubMed ID: 20724919
[TBL] [Abstract][Full Text] [Related]
8. Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues.
Wu GJ; Varma VA; Wu MW; Wang SW; Qu P; Yang H; Petros JA; Lim SD; Amin MB
Prostate; 2001 Sep; 48(4):305-15. PubMed ID: 11536311
[TBL] [Abstract][Full Text] [Related]
9. METCAM/MUC18 promoted tumorigenesis of human breast cancer SK-BR-3 cells in a dosage-specific manner.
Huang CY; Wu GJ
Taiwan J Obstet Gynecol; 2016 Apr; 55(2):202-12. PubMed ID: 27125403
[TBL] [Abstract][Full Text] [Related]
10. METCAM/MUC18 augments migration, invasion, and tumorigenicity of human breast cancer SK-BR-3 cells.
Zeng G; Cai S; Liu Y; Wu GJ
Gene; 2012 Jan; 492(1):229-38. PubMed ID: 22057013
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of METCAM/MUC18 promotes motility, invasion, and tumorigenesis of human breast cancer cells.
Zeng GF; Cai SX; Wu GJ
BMC Cancer; 2011 Mar; 11():113. PubMed ID: 21450088
[TBL] [Abstract][Full Text] [Related]
12. Enforced Expression of METCAM/MUC18 Decreases In Vitro Motility and Invasiveness and Tumorigenesis and In Vivo Tumorigenesis of Human Ovarian Cancer BG-1 Cells.
Wu GJ
Adv Exp Med Biol; 2021; 1330():125-137. PubMed ID: 34339034
[TBL] [Abstract][Full Text] [Related]
13. [Expressions of Ki67, PCNA and mitotic index in ovarian epithelial tumors].
Wang S; Ma XY; Xia Y; Zhang LH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):575-80. PubMed ID: 20848772
[TBL] [Abstract][Full Text] [Related]
14. MCAM is a novel metastasis marker and regulates spreading, apoptosis and invasion of ovarian cancer cells.
Wu Z; Wu Z; Li J; Yang X; Wang Y; Yu Y; Ye J; Xu C; Qin W; Zhang Z
Tumour Biol; 2012 Oct; 33(5):1619-28. PubMed ID: 22610942
[TBL] [Abstract][Full Text] [Related]
15. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
[TBL] [Abstract][Full Text] [Related]
17. Association of expression of XIAP-associated factor 1 (XAF1) with clinicopathologic factors, overall survival, microvessel density and cisplatin-resistance in ovarian cancer.
Wang Y; Mao H; Hao Q; Wang Y; Yang Y; Shen L; Huang S; Liu P
Regul Pept; 2012 Oct; 178(1-3):36-42. PubMed ID: 22759793
[TBL] [Abstract][Full Text] [Related]
18. Dub3 expression correlates with tumor progression and poor prognosis in human epithelial ovarian cancer.
Zhou B; Shu B; Xi T; Su N; Liu J
Biomed Pharmacother; 2015 Mar; 70():84-9. PubMed ID: 25776484
[TBL] [Abstract][Full Text] [Related]
19. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
Rosen DG; Wang L; Jain AN; Lu KH; Luo RZ; Yu Y; Liu J; Bast RC
Clin Cancer Res; 2004 Oct; 10(19):6559-66. PubMed ID: 15475444
[TBL] [Abstract][Full Text] [Related]
20. Epithelial protein lost in neoplasm-α (EPLIN-α) is a potential prognostic marker for the progression of epithelial ovarian cancer.
Liu R; Martin TA; Jordan NJ; Ruge F; Ye L; Jiang WG
Int J Oncol; 2016 Jun; 48(6):2488-96. PubMed ID: 27035883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]